13.07.2015 Views

Biochemistry/Molecular Biology - ARVO

Biochemistry/Molecular Biology - ARVO

Biochemistry/Molecular Biology - ARVO

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>ARVO</strong> 2013 Annual Meeting Abstracts by Scientific Section/Group - <strong>Biochemistry</strong>/<strong>Molecular</strong> <strong>Biology</strong>Qiong Ding 1 , Michael G. Anderson 2 , Amy Cook 1 , Markus H. Kuehn 1 .1 Ophthalmology and Visual Sciences, U of Iowa, Iowa City, IA;2 <strong>Molecular</strong> Physiology and Biophysics, U of Iowa, Iowa City, IA.Purpose: The development of glaucoma is associated with activationof the complement cascade and the marked accumulationcomplement components 1q (C1q) and 3 (C3) in association withretinal ganglion cells (RGC). In order to determine the functionalsignificance of C1q and C3 in the pathophysiology of glaucoma, weevaluated retinal ganglion cell (RGC) and axonal loss in B6-Sh3pxd2nee (nee) mice with and without targeted deletions in either the C1qaor C3 genes.Methods: Nee mice were bred either with those containing targeteddeletions in C1q or C3 to create double knockouts. At 8 weeks of agethe intraocular pressure (IOP) was determined using a reboundtonometer. The animals were then euthanized and the eyes and opticnerves were harvested. The number of surviving gamma synucleinimmunoreactive RGC was determined in flat mounted preparations ofretina and axonal damage in the optic nerve was evaluated using a 5-point grading scheme. Differences between strains were evaluatedusing either one way ANOVA or Kruskal-Wallis test.Results: The presence of the nee allele caused a marked elevation ofIOP above that observed in control mice (+6.0 mmHg, p=0.0002),but no difference was observed with respect to the absence orpresence of functional complement genes. The elevation in IOPcaused a decline in RGC numbers and an increase in optic nervedamage scores. Among mice homozygous for the nee mutation, theobserved damage was particularly marked in C1q-/- (-74.3%) miceand significantly higher than that observed in C3-/- mice or littermatecontrols (-33.6% and -32.3%, respectively, p160 nt). Smaller chimeras allow3D RNA algorithms for structural design and biophysicalinvestigation of hhRz structure/function performance.Methods: CELO-VAI scaffold, designed using RNAStructure, wasPCR constructed with partially overlapping DNA primers, thendirectionally ligated into pNEB193-T7. hhRz cDNA or controlsequence was cloned into an adapter placed at a unique CELO-VAIrestriction site. Target hRHO fragment cDNA (510 nt RNA)containing the hhRz cleavage site was cloned into pBlueScript.Transcription with T7 RNA polymerase generated chimeric CELO-VAI-hhRzs and target RNA to test in vitro cleavage. In HEK293 cellsfull length hRHO cDNA was expressed from pCDNA3.1, and CELO-VAI-hhRzs or controls (in pNEB193-T7) were expressed from strongintragenic Pol-III promoters. hRHO mRNA was assayed byquantitative RT/PCR with controls. ANOVA and t-tests were used tostatistically evaluate outcomes.Results: The hhRz that demonstrated cellular cleavage activitywithin a larger human VAI RNA scaffold had only pure antisensetarget suppression (64% knockdown, p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!